Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioma × Drug Therapy × Clear all

Phase

Phase 2 4 Phase NA 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Pancreatic Neoplasms 10 Neoplasms 9 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Squamous Cell Carcinoma of Head and Neck 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Glioblastoma 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Neuroblastoma 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Head and Neck Neoplasms 4 Fallopian Tube Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Brain Neoplasms 4 Recurrence 3 Gliosarcoma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Astrocytoma 3 Advanced Solid Tumors 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Mesothelioma, Malignant 2

Interventions

Temozolomide 41 Radiotherapy 15 Magnetic Resonance Spectroscopy 12 Surgical Procedures, Operative 10 Irinotecan 9 Bevacizumab 9 Radiation 8 Nivolumab 7 Carmustine 7 Specimen Handling 6 Radiosurgery 6 Carboplatin 6 ribociclib 5 O(6)-benzylguanine 5 Imiquimod 5 IL13-PE38 5 Flucytosine 5 Filgrastim 5 Erlotinib Hydrochloride 5 Aminolevulinic Acid 5 vandetanib 4 sargramostim 4 Topotecan 4 Imatinib Mesylate 4 Etoposide 4 Cyclophosphamide 4 Craniotomy 4 vocimagene amiretrorepvec 3 temsirolimus 3 lentiviral minigene vaccine of COVID-19 coronavirus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03739411 2026-03-27

Hyperpolarized Imaging in Diagnosing Participants With Glioma

University of California, San Francisco

Phase 1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡